User profiles for Alessandra Cavaliere

Alessandra Cavaliere

Yale University
Verified email at yale.edu
Cited by 223

Fluorinated nucleosides as an important class of anticancer and antiviral agents

A Cavaliere, KC Probst, AD Westwell… - Future Medicinal …, 2017 - Future Science
Fluorine-containing nucleoside analogs (NAs) represent a significant class of the US FDA-approved
chemotherapeutics widely used in the clinic. The incorporation of fluorine into drug-…

Aluminum Modulates Effects of βAmyloid1–42 on Neuronal Calcium Homeostasis and Mitochondria Functioning and Is Altered in a Triple Transgenic Mouse Model …

D Drago, A Cavaliere, N Mascetra… - Rejuvenation …, 2008 - liebertpub.com
Recent findings suggest that β-amyloid (Aβ) is more neurotoxic when present in its oligomeric
configuration rather than as monomers or fibrils. Previous work from our laboratories has …

Alginate Oligosaccharide-Induced Modification of the lasI-lasR and rhlI-rhlR Quorum-Sensing Systems in Pseudomonas aeruginosa

…, K Beck, H Sadh, L Sutton, A Cavaliere… - Antimicrobial Agents …, 2018 - Am Soc Microbiol
Pseudomonas aeruginosa plays a major role in many chronic infections. Its ability to readily
form biofilms contributes to its success as an opportunistic pathogen and its resistance/…

Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma

…, JH Lee, T Lee, HW Suh, S Lee, A Cavaliere… - Science Translational …, 2023 - science.org
The morbidity associated with pediatric medulloblastoma, in particular in patients who
develop leptomeningeal metastases, remains high in the absence of effective therapies. …

Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer

A Cavaliere, S Sun, S Lee, J Bodner, Z Li… - European journal of …, 2021 - Springer
Background Amivantamab is a novel bispecific antibody that simultaneously targets the
epidermal growth factor receptor (EGFR) and the hepatocyte growth factor receptor (HGFR/c-…

Virtual screening, SAR, and discovery of 5‐(indole‐3‐yl)‐2‐[(2‐nitrophenyl) amino][1, 3, 4]‐oxadiazole as a novel Bcl‐2 inhibitor

NI Ziedan, R Hamdy, A Cavaliere… - Chemical biology & …, 2017 - Wiley Online Library
A new series of oxadiazoles were designed to act as inhibitors of the anti‐apoptotic Bcl‐2
protein. Virtual screening led to the discovery of new hits that interact with Bcl‐2 at the BH 3 …

[HTML][HTML] Preclinical advances in theranostics for the different molecular subtypes of breast cancer

H Fang, A Cavaliere, Z Li, Y Huang… - Frontiers in …, 2021 - frontiersin.org
Breast cancer is the most common cancer in women worldwide. The heterogeneity of breast
cancer and drug resistance to therapies make the diagnosis and treatment difficult. …

[89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B–targeted Therapy in Triple-negative Breast Cancer

S Lee, A Cavaliere, JD Gallezot, T Keler… - Molecular Cancer …, 2022 - AACR
There is a need for prognostic markers to select patients most likely to benefit from antibody–drug
conjugate (ADC) therapy. We quantified the relationship between pretreatment PET …

[HTML][HTML] ImmunoPET Imaging Identifies the Optimal Timepoint for Combination Therapy in Xenograft Models of Triple-Negative Breast Cancer

Z Li, E Belitzky, O Blaha, A Cavaliere, SR Katz… - Cancers, 2023 - mdpi.com
Simple Summary Different combination therapies are being investigated for the treatment of
triple-negative breast cancer (TNBC). Dasatinib is one such drug that targets the Src …

[HTML][HTML] Radiosynthesis of [18F]-Labelled Pro-Nucleotides (ProTides)

A Cavaliere, KC Probst, SJ Paisey, C Marshall… - Molecules, 2020 - mdpi.com
Phosphoramidate pro-nucleotides (ProTides) have revolutionized the field of anti-viral and
anti-cancer nucleoside therapy, overcoming the major limitations of nucleoside therapies and …